- Home
- MOMO vs IMNM Comparison
MOMO vs IMNM Comparison
Compare MOMO & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOMO
- IMNM
- Stock Information
- Founded
- MOMO 2011
- IMNM 2006
- Country
- MOMO China
- IMNM United States
- Employees
- MOMO N/A
- IMNM N/A
- Industry
- MOMO Computer Software: Prepackaged Software
- IMNM Medicinal Chemicals and Botanical Products
- Sector
- MOMO Technology
- IMNM Health Care
- Exchange
- MOMO Nasdaq
- IMNM Nasdaq
- Market Cap
- MOMO 909.4M
- IMNM 748.3M
- IPO Year
- MOMO 2014
- IMNM 2020
- Fundamental
- Price
- MOMO $8.28
- IMNM $8.75
- Analyst Decision
- MOMO Buy
- IMNM Strong Buy
- Analyst Count
- MOMO 2
- IMNM 5
- Target Price
- MOMO $10.00
- IMNM $26.40
- AVG Volume (30 Days)
- MOMO 1.6M
- IMNM 828.8K
- Earning Date
- MOMO 06-05-2025
- IMNM 08-11-2025
- Dividend Yield
- MOMO 3.37%
- IMNM N/A
- EPS Growth
- MOMO N/A
- IMNM N/A
- EPS
- MOMO 1.06
- IMNM N/A
- Revenue
- MOMO $1,450,201,337.00
- IMNM $10,938,000.00
- Revenue This Year
- MOMO $0.97
- IMNM N/A
- Revenue Next Year
- MOMO $4.25
- IMNM $349.38
- P/E Ratio
- MOMO $8.11
- IMNM N/A
- Revenue Growth
- MOMO N/A
- IMNM N/A
- 52 Week Low
- MOMO $5.12
- IMNM $5.15
- 52 Week High
- MOMO $8.66
- IMNM $16.81
- Technical
- Relative Strength Index (RSI)
- MOMO 73.10
- IMNM 48.43
- Support Level
- MOMO $8.16
- IMNM $9.02
- Resistance Level
- MOMO $8.66
- IMNM $9.91
- Average True Range (ATR)
- MOMO 0.30
- IMNM 0.55
- MACD
- MOMO 0.11
- IMNM -0.08
- Stochastic Oscillator
- MOMO 85.38
- IMNM 9.37
About MOMO Hello Group Inc.
Hello Group Inc provides mobile-based social networking services. It enables users to establish and expand social relationships based on location and interests. Its platform includes the Momo mobile application and a variety of related features, functionalities, tools, and services that it provides to users, customers, and platform partners. The company derives its revenue from live video services, value-added services, mobile marketing services, mobile games, and other services. It operates in three segments: Momo's service lines, Tantan's service lines, and QOOL's service lines, out of which Momo's service lines segment derives the majority of revenue.
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.